Will you be at #FOG2025? Email us at info@biorelate.com to book a 1:1 demo of the most advanced causal #ArtificialIntelligence capabilities in the #biopharma industry
The Festival of Genomics & Biodata is BACK with more topics, more choice and more speakers! After last year’s record attendance, #FOG2025 is now the UK’s largest life sciences event. So, mark your calendars and join us in London in January: hubs.la/Q02TrNTn0#genomics
The Festival of Genomics & Biodata is BACK with more topics, more choice and more speakers! After last year’s record attendance, #FOG2025 is now the UK’s largest life sciences event. So, mark your calendars and join us in London in January: hubs.la/Q02TrNTn0#genomics
Biorelate CEO Daniel Jamieson joins other leading pharma thinkers in the Reflections and Predictions issue of PharmaTimes Magazine magazine.pharmatimes.com/col…
Last chance to participate in today's webinar. Registering will also guarantee the recording is sent to you even if you don't attend the live event>> webinars.biorelate.com/knowl…
#BiotechShowcase is the premier investor conference for private, small-cap, seed and techbio companies, offering a prime opportunity to connect with #investors who drive deals forward.
Register before Nov. 8 and save €400 >> spr.ly/6016qAO9y
A unique opportunity to participate in a forum for #bioinformatics and data scientists from around the world. Leading #knowledgegraph#drugdiscovery experts will share their case studies, followed by a Q&A and panel discussion. Register >> lnkd.in/eQ2m_G_m
We look forward to attending
@BioTechX_ USA taking place in the Pennsylvania Convention Center this week on Sep 17-18. Catch us at booth 624 and see our talk on Day 1 on the Bioinformatics track#biotechx
We look forward to attending
@BioTechX_ USA taking place in the Pennsylvania Convention Center this week on Sep 17-18. Catch us at booth 624 and see our talk on Day 1 on the Bioinformatics track#biotechx
One month until #biotechx@BioTechX_ USA in Phili Sept 17-18. Email us to book a 1:1 demo to see the new evidence that could be at your fingertips to support better target selection, understanding mechanism of action, indication expansion and other key drug discovery areas.
We’ve just launched additional Galactic API endpoints, which provide new functionality including the ability to search and identify protein or chemical biomarkers associated with a disease of interest.
Identifying biological concepts that are most relevant to your search is one of many functionalities aiding better target prioritisation. Visit biorelate.com to discover more and request a demo.
Newly launched Galactic API endpoints provide increased knowledge graph querying capabilities, including identifying direct binding interactions, giving you greater confidence in your choice of drug target.
Galactic AI™’s cutting-edge NER capabilities underpin the most advanced recognition of proteins and diseases in biomedical text; the available insights are ever-expanding with the recent Galactic Data v2.13 release. We continue to embrace LLMs to take this even further.